Literature DB >> 8961715

U.S. military overseas medical research laboratories.

J M Gambel1, R G Hibbs.   

Abstract

Many infectious disease threats to U.S. military operations are uncommon in the United States. The advanced development and testing of countermeasures, such as vaccines, drugs, or insect repellents, requires the capability to study militarily important infectious diseases where they occur. With formal agreements between the U.S. and each host country, the U.S. military operates seven overseas medical research laboratories (labs). Six labs conduct infectious disease research and are distributed over three continents: Africa (labs in Egypt and Kenya), Asia (labs in Indonesia and Thailand), and South America (labs in Brazil and Peru). One other lab is located in Germany and conducts psychosocial research related to military personnel and their families. In addition to product development, these labs play vital roles supporting overseas deployments, providing technical training, and promoting international relations. Also, these labs are well positioned to become part of a developing global surveillance and response system to help address the threat posed by emerging infectious diseases. This article will present an overview of this unique medical research capability, describe the history and some of the activities of each lab, and discuss the importance of maintaining these labs in the 21st century.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8961715

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  7 in total

1.  The importance of militaries from developing countries in global infectious disease surveillance.

Authors:  Jean-Paul Chretien; David L Blazes; Rodney L Coldren; Michael D Lewis; Jariyanart Gaywee; Khunakorn Kana; Narongrid Sirisopana; Victor Vallejos; Carmen C Mundaca; Silvia Montano; Gregory J Martin; Joel C Gaydos
Journal:  Bull World Health Organ       Date:  2007-03       Impact factor: 9.408

2.  Global Infectious Disease Surveillance at DoD Overseas Laboratories, 1999-2007.

Authors:  J Jeremy Sueker; Jean-Paul Chretien; Joel C Gaydos; Kevin L Russell
Journal:  Am J Trop Med Hyg       Date:  2010-01       Impact factor: 2.345

3.  Microbiological laboratory results from Haiti: June-October 1995.

Authors:  J J Drabick; J M Gambel; E Huck; S De Young; L Hardeman
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

4.  International Health Regulations (2005) and the U.S. Department of Defense: building core capacities on a foundation of partnership and trust.

Authors:  Matthew C Johns; David L Blazes
Journal:  BMC Public Health       Date:  2010-12-03       Impact factor: 3.295

Review 5.  A growing global network's role in outbreak response: AFHSC-GEIS 2008-2009.

Authors:  Matthew C Johns; Ronald L Burke; Kelly G Vest; Mark Fukuda; Julie A Pavlin; Sanjaya K Shrestha; David C Schnabel; Steven Tobias; Jeffrey A Tjaden; Joel M Montgomery; Dennis J Faix; Mark R Duffy; Michael J Cooper; Jose L Sanchez; David L Blazes; Sonam Wangchuk; Tandin Dorji; Robert Gibbons; Sopon Iamsirithaworn; Jason Richardson; Rome Buathong; Richard Jarman; In-Kyu Yoon; Geeta Shakya; Victor Ofula; Rodney Coldren; Wallace Bulimo; Rosemary Sang; Duke Omariba; Beryl Obura; Dennis Mwala; Matthew Kasper; Gary Brice; Maya Williams; Chad Yasuda; Robert V Barthel; Guillermo Pimentel; Chris Meyers; Peter Kammerer; Darcie E Baynes; David Metzgar; Anthony Hawksworth; Patrick Blair; Melody Ellorin; Robert Coon; Victor Macintosh; Kristen Burwell; Elizabeth Macias; Thomas Palys; Kurt Jerke
Journal:  BMC Public Health       Date:  2011-03-04       Impact factor: 3.295

6.  Using standard and institutional mentorship models to implement SLMTA in Kenya.

Authors:  Ernest P Makokha; Samuel Mwalili; Frank L Basiye; Clement Zeh; Wilfred I Emonyi; Raphael Langat; Elizabeth T Luman; Jane Mwangi
Journal:  Afr J Lab Med       Date:  2014-11-03

7.  Experience of a global laboratory network in responding to infectious disease epidemics.

Authors:  Jean-Paul Chretien; David L Blazes; Joel C Gaydos; Sheryl A Bedno; Rodney L Coldren; Randall C Culpepper; David J Fyrauff; Kenneth C Earhart; Moustafa M Mansour; Jonathan S Glass; Michael D Lewis; Bonnie L Smoak; Joseph L Malone
Journal:  Lancet Infect Dis       Date:  2006-09       Impact factor: 25.071

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.